留学主题咨询

立即预约
￥420
芝士圈微信群成员首单优惠价 ￥399  加入芝士圈微信群>>
微信扫码发送「咨询群优惠」进群

美英澳-硕士-卫生经济学/药物经济学-择校

其他 药物经济学 Health Economic and Outcome Research Health Technology Assessment 卫生经济学‘
  • 课程简述: 美英澳卫生经济学/药物经济学硕士项目申请推荐
  • 适用用户: 想要攻读美英澳学校卫生经济学/药物经济学专业硕士研究生的同学

美英澳选校推荐（6所，可自由搭配地区，例：三所美国高校+三所英国高校）

专业：卫生经济学/药物经济学

分类：冲刺+主要申请+保底

具体：项目名称+课程大纲+学校评分

例子：

Program name: MSc Health Economics

University: University of York

Country: UK

Link: https://www.york.ac.uk/study/postgraduate-taught/courses/msc-health-economics/

Mark: 4.5 (Full score 5)

 

 

立即预约
￥140
芝士圈微信群成员首单优惠价 ￥133  加入芝士圈微信群>>
微信扫码发送「咨询群优惠」进群

美英澳-硕士-卫生经济学/药物经济学-专业咨询

其他 药物经济学 卫生经济学 Health Economic and Outcome Research Health Technology Assessment
  • 课程简述: 美英澳卫生经济学/药物经济学硕士项目咨询
  • 适用用户: 想要攻读美英澳学校卫生经济学/药物经济学专业硕士研究生的同学

自我介绍

自我介绍

研究经历涵盖了医疗大数据/真实数据分析, 药物经济学, 卫生健康技术评估, 药物流行病学, 机器学习, 生物信息学.

Experienced in Big medical data/Real World Evidence, Pharmacoeconomics, Health Technology Assessment (HTA), Pharmacoepidemiology, Machine learning, Bioinformatic.



教育经历

教育

The University of Hong Kong

PH.D Pharmacoeconomics and Pharmacoepidemiology
~

Johns Hopkins University

Master Health Economic and Outcome Research
~

Shenyang Pharmaceutical University

Bachelor Pharmacy
~

经历

Research Assistant

The University of Hong Kong
~
  •  Using Markov-model to assess the cost-effectiveness of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in Hong Kong.
  • Using IQVIA-MIDAS sales audit data, conducted an interrupted time series analysis to explore the impact of biosimilars on the sales volumes and price of their reference biologics.
  • Assisted (Data collection, manipulation, and statistical analysis) a retrospective case-control study to investigate the association between the covid-19 vaccination and occurrence of carditis in Hong Kong.
  • Assisted (Data collection, manipulation, and statistical analysis) a prospective cohort study to compare the self-reported adverse reaction following the use of two types of covid-19 vaccine in Hong Kong.
  • Designed and distributed a questionnaire to understand the barriers of using biologic/targeted synthetic disease-modifying antirheumatic drugs (DMARDs) among patients with autoimmune diseases in Hong Kong.
  • Conducted a systematic review on the cost-effectiveness of biologic/targeted synthetic DMARDs in treating autoimmune diseases

获奖 & 荣誉

发表文章

服务评价

  • 还没有收到过评论

分享行家主题

Share to WeChat
Share to Sina Weibo Share to Qzone Share to Douban Share to LinkedIn Share to Tencent QQ Share to Email App
Copyright © 2012~2024 南京雷贝教育信息科技有限公司. 保留所有权利.
苏ICP备14023230号-2 ｜公安备案苏公网安备 32011302320939号